In C57BL/6J mice with stenosis-induced VTE, elevated levels of miR-338-5p led to reduced IL-6 expression and decreased DVT formation, highlighting miR-338-5p as a potential therapeutic target. This evidence concerns the gene IL6 and deep vein thrombosis.